Roche Names O’Day Pharma Head as Soriot Becomes AstraZeneca CEO
O’Day will begin the position Sept. 1, the Basel, Switzerland-based company said today in an e-mailed statement. Roland Diggelmann will succeed O’Day as head of diagnostics, Roche said.
Diggelmann is currently head of the Asia-Pacific region for the diagnostics unit.
To contact the reporter on this story: Thomas Mulier in Geneva at firstname.lastname@example.org
To contact the editor responsible for this story: David Risser at email@example.com